These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37704043)

  • 1. Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
    Sakthivel M; Wolff H; Monast K; McHugh A; Stulberg D; Janiak E
    Contraception; 2024 Feb; 130():110280. PubMed ID: 37704043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB
    Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Calloway D; Stulberg DB; Janiak E
    Contraception; 2021 Jul; 104(1):24-28. PubMed ID: 33891965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Srinivasulu S; Yavari R; Brubaker L; Riker L; Prine L; Rubin SE
    Contraception; 2021 Jul; 104(1):92-97. PubMed ID: 33910031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Lee CM; Johns SL; Stulberg DB; Allen RH; Janiak E
    Contraception; 2023 Jan; 117():39-44. PubMed ID: 35970423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.
    Raifman S; Gurazada T; Beaman J; Biggs MA; Schwarz EB; Gold M; Grossman D
    BMC Womens Health; 2024 Jul; 24(1):382. PubMed ID: 38956609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.
    Wagner MS; Munro S; Wilcox ES; Devane C; Norman WV; Dunn S; Soon JA; Guilbert É
    J Obstet Gynaecol Can; 2020 May; 42(5):576-582. PubMed ID: 31924442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study.
    Munro S; Guilbert E; Wagner MS; Wilcox ES; Devane C; Dunn S; Brooks M; Soon JA; Mills M; Leduc-Robert G; Wahl K; Zannier E; Norman WV
    Ann Fam Med; 2020 Sep; 18(5):413-421. PubMed ID: 32928757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA.
    Neill S; Mokashi M; Goldberg A; Fortin J; Janiak E
    Perspect Sex Reprod Health; 2023 Sep; 55(3):210-217. PubMed ID: 37394759
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wu L; Nutting K; Harriett L; McHugh A; Janiak E; Stulberg DB
    Ann Fam Med; 2023; 21(5):468. PubMed ID: 37100465
    [No Abstract]   [Full Text] [Related]  

  • 13. Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
    Fiastro AE; Young E; Jacob-Files E; Ruben MR; Coeytaux FM; Bennett IM; Godfrey EM
    Contraception; 2023 Jul; 123():110050. PubMed ID: 37085094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
    Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA
    Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation.
    Guilbert E; Wagner MS; Munro S; Wilcox ES; Dunn S; Soon JA; Devane C; Norman WV
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):190-198. PubMed ID: 32312130
    [No Abstract]   [Full Text] [Related]  

  • 17. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
    Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S
    Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.
    Devane C; Renner RM; Munro S; Guilbert É; Dunn S; Wagner MS; Norman WV
    Pilot Feasibility Stud; 2019; 5():126. PubMed ID: 31720004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging an implementation science partnership network to understand how Federally Qualified Health Centers operationalize and address health equity.
    Aschbrenner KA; Cruz JL; Kruse GR; Nguyen H; Huebner Torres C; Celli M; Sarcione C; Singh D; Emmons KM
    Transl Behav Med; 2024 Jan; 14(1):23-33. PubMed ID: 37542519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative inquiry into barriers and facilitators to transforming primary care for lesbian, gay, bisexual and transgender people in US federally qualified health centres.
    Gagnon KW; Bifulco L; Robinson S; Furness B; Lentine D; Anderson D
    BMJ Open; 2022 Feb; 12(2):e055884. PubMed ID: 35177460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.